/ Pipeline
Developing first- and best-in-class precision medicines
Sudo is rapidly advancing fit-for-purpose compounds for neurological and immunological conditions.
Our Pipeline
| Preclinical | Phase 1 | Phase 2 | Phase 3 | Commercial |
SUDO-550
Brain-penetrant oral
Multiple Sclerosis, other neurodegenerative diseases with underlying neuroinflammation
Phase 1
SUDO-286
Dermal topical
Dermatological conditions
Phase 1
Ophthalmic
Ophthalmological conditions
Pre-clinical
Meet the company’s leadership
